(Date:11/9/2009)... WHAT: All PETCO stores nationwide will host a...ated by specially trained in-store nutrition, .... During the 30-minute, workshop, pe...f, their dogs and cats, have a chance... nutrition, receive an assessment of their individ...
(Date:11/9/2009)...e University of Florida Proton Therapy Institute h...py for St. Jude patients. The announcement follows...ate the use of proton therapy for rare brain cance...er the clinical protocol, St. Jude will refer pati...erapy Institute in Jacksonville, Fla. The purpose ...
(Date:11/9/2009)... European Urology , the official journal of the E...e entitled ,Are Infertile Men Less Healthy than Fe...urvey, by Dr. Andrea Salonia et al. The conclusion...h a number of medical comorbidities, as objectivel...ity Index. , Dr. Andrea Salonia from the Univers...
(Date:11/9/2009)...try, respiratory disease, often leading to disabil...lic health concern. Studies led by Deborah Young-...l of Construction, have shown that specific types ...the dust that causes these health hazards, yet the...ins very low. , To find out why, Young-Corbett c...
(Date:11/9/2009)...n embryonic stem cell treatment approved by the FD... function in rats with neck spinal cord injuries ...include people with cervical damage. , In Januar...Corp. of Menlo Park, Calif., permission to test th... spinal cord injuries, which occur below the neck....
Breaking Medicine News(10 mins):Health News:St. Jude and UF Proton Therapy Institute to begin proton therapy clinical trial 2Health News:European Urology: Male factor infertility associated with comorbidities 2Health News:Dust control research leads to a NIOSH grant to facilitate adoption of hazard controls 2Health News:Dust control research leads to a NIOSH grant to facilitate adoption of hazard controls 3Health News:UCI embryonic stem cell therapy restores walking ability in rats with neck injuries 2...ad Effort to Deliver Trusted Clinical Knowledge vi... Elsevier, the leading publisher of scientific,...y that Chris Dillon has joined Elsevier Health,Sci...ing product development, marketing and sales. He w...
...//www.EvasVillage.org ), a comprehensive New Jerse...e in need in 2009, and a decline in foundation gra...n, New Jersey, seeks additional funding to meet th...rams and a decline in foundation grants and gifts...
...ation Management, Inc., now celebrating their 25th...ategic partner for brand strategy and communicatio...H (PRWEB) May 27, 2009 -- Cleveland-based Litigat...tion design, visualizations, online presence, adve...
...16 , , BATTLE CREEK, Mich., May 21 The Interna...announced today that it will deliver its inaugural...d Safety" -- on July 14-16, 2009 at the McCamly Pl...ining to all State, local, tribal and territorial ...
...entral Valley , , MOUNTAIN VIEW, Calif., May 26 ...d leading providers of kidney dialysis services an...nounced their participation at the National Kidney...Satellite Healthcare,s commitment to kidney health...
...ny,s Twelve Nominees , , SAN DIEGO, May 26 Amyl...eminded its shareholders to use their BLUE proxy c...g its two new independent Director nominees: Paul .... , , Amylin,s 2009 Annual Meeting of Stockholder...
Other Medicine News:Health News:Elsevier Appoints Chris Dillon as Managing Director, Clinical Decision Support 2Health News:Elsevier Appoints Chris Dillon as Managing Director, Clinical Decision Support 3Health News:Eva's Village, a Comprehensive New Jersey Anti-Poverty charity, Seeks Additional Funding to Meet the Increasing Need Along with a Decline in Donations 2Health News:Eva's Village, a Comprehensive New Jersey Anti-Poverty charity, Seeks Additional Funding to Meet the Increasing Need Along with a Decline in Donations 3Health News:Eva's Village, a Comprehensive New Jersey Anti-Poverty charity, Seeks Additional Funding to Meet the Increasing Need Along with a Decline in Donations 4Health News:Eva's Village, a Comprehensive New Jersey Anti-Poverty charity, Seeks Additional Funding to Meet the Increasing Need Along with a Decline in Donations 5Health News:Boondock Walker Elevates LMI with Innovative Strategic Communications 2Health News:International Food Protection Training Institute to Deliver Inaugural Training Course to Food Safety Regulators 2Health News:International Food Protection Training Institute to Deliver Inaugural Training Course to Food Safety Regulators 3Health News:Satellite Healthcare Walks for Kidney Health 2Health News:Amylin Advises All Shareholders to Vote Their Blue Proxy Card Today 2Health News:Amylin Advises All Shareholders to Vote Their Blue Proxy Card Today 3Health News:Amylin Advises All Shareholders to Vote Their Blue Proxy Card Today 4(Date:11/9/2009)...wire-FirstCall/ -- Clarient, Inc. (Nasdaq: CLRT )...athologists, oncologists and the pharmaceutical in...ke presentations at two upcoming investor conferen... will be made at the Lazard Capital Markets Sixth ...sday, November 17. The conference will be held at ...
(Date:11/7/2009)...re/ -- Patients reported C1-esterase inhibitor (C1...ing acute swelling attacks at any body location fo...ing to data presented today at the 2009 American C... Annual Meeting. The results come from a self-repo... the ongoing, prospective, open label I nternatio...
(Date:11/6/2009)...rstCall/ -- Oxygen Biotherapeutics, Inc. (OTC Bull...y approved reverse split of its common stock will .... 9, 2009 on a 1-for-15 split-adjusted basis. Oxyg...he new symbol OXBT. The stock also will have a new... effective. ,, "This reverse split was overwhel...
Breaking Medicine Technology:Clarient to Present at Upcoming Healthcare Investor Conferences in New York City 2Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 2Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 3Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 2Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 3Prospect Therapeutics In Vitro Studies Demonstrate that GCS 100 Drug Binds to and Blocks the Effects of Galectin 3 48875 1Prospect Therapeutics In Vitro Studies Demonstrate that GCS 100 Drug Binds to and Blocks the Effects of Galectin 3 48875 2Angel MedFlight Provides Air Medical Transportation for Accident Victim Needing Transport from France to U S 48871 1Angel MedFlight Provides Air Medical Transportation for Accident Victim Needing Transport from France to U S 48871 2Angel MedFlight Provides Air Medical Transportation for Accident Victim Needing Transport from France to U S 48871 3Quest Diagnostics to Speak at the Jefferies 3rd Annual Healthcare Conference 48867 1...IA, Pa., Sept. 4 GlaxoSmithKline,(NYSE: GSK ) to...demonstrate,combination treatment with AVODART (du...es significantly greater urinary symptom improveme...ART or tamsulosin monotherapy,over 24 months. Thre...th,Avodart and tamsulosin (CombAT) - were presente...
...alif., Sept. 4 Quark Pharmaceuticals, Inc., a,cli...iscovering and,developing novel RNA interference-b...Marr, M.D. has been appointed as the Company,s new...r will play a key role in supporting Quark,s,curre...d plans of the,Company,s pipeline. Prior to joini...
Other Medicine Technology:Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years 2Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years 3Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years 4Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years 5Quark Pharmaceuticals Appoints New Chief Medical Officer 2Quark Pharmaceuticals Appoints New Chief Medical Officer 3Quark Pharmaceuticals Appoints New Chief Medical Officer 4Premier Encore Mini C-Arm
KM-500 Hand-Held Auto Keratometer
Herrick Lacrimal Plugs
Khosla Cryo Ultra
Medicine Products: